Aging Demographics And Modern Outpatient Demand Will Transform Value

Published
20 Mar 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$17.38
5.2% undervalued intrinsic discount
14 Aug
US$16.47
Loading
1Y
-6.0%
7D
-0.5%

Author's Valuation

US$17.4

5.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 0.60%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 0.96%

AnalystConsensusTarget has increased revenue growth from -1.9% to -1.7%.

Shared on09 Apr 25
Fair value Increased 4.59%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 3.07%

Shared on26 Mar 25
Fair value Decreased 3.06%

AnalystConsensusTarget has increased revenue growth from -2.2% to -0.1%, decreased profit margin from 20.0% to 17.2%, increased future PE multiple from 27.4x to 32.1x and increased shares outstanding growth rate from -0.1% to -0.0%.